Fingerprint
Dive into the research topics of 'Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
Veronika Dill, Johanna Kauschinger, Richard T. Hauch, Lars Buschhorn, Timo O. Odinius, Catharina Müller-Thomas, Ritu Mishra, Michele C. Kyncl, Burkhard Schmidt, Peter M. Prodinger, Dirk Hempel, Frauke Bellos, Alexander Höllein, Wolfgang Kern, Torsten Haferlach, Julia Slotta-Huspenina, Florian Bassermann, Christian Peschel, Katharina S. Götze, Irene C. Waizenegger
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations